Ascites Treatment Method Challenged In New Inter Partes Review Petition
ALEXANDRIA, Va. — A patented method of administering the peptide drug terlipressin as a continuous infusion to ascites patients on an outpatient basis is both anticipated and rendered obvious by prior...To view the full article, register now.
Already a subscriber? Click here to view full article